官方服务：
资源简介：
Concomitant immunomodulating therapy during treatment.
应用场景：
创建时间：
2024-01-23
相关数据集
Additional file 1: of New therapeutic targeting of Alzheimer’s disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study
Data set. (XLSX 18 kb)
DataCite Commons2020-08-27 更新40
Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis
Immuno-modulators in combination with antileishmanial drug miltefosine is a better therapeutic approach for treatment of Visceral Leishmaniasis (VL) as it not only reduces the dose of miltefosine but
NIAID Data Ecosystem30
Daratumumab in systemic lupus erythematosus: a phase 2 trial
Antibody-secreting cells (ASCs) play a central role in the pathophysiology of systemic lupus erythematosus (SLE). This single-arm, open-label, phase 2 clinical trial aimed to evaluate the safety and e
NIAID Data Ecosystem10
CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway
Cultivating an environment of mutualism between host cells and the microbiota is vital, and dysregulation of this relationship is associated with multiple immune disorders including metabolic and skin
NIAID Data Ecosystem40
Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells
Narrowband ultraviolet B (NB-UVB) has been widely used in dermatological phototherapy. As for the application of NB-UVB phototherapy to graft-versus-host disease (GVHD), we previously reported that it
NIAID Data Ecosystem20
